Big news in the peptide world. , The FDA has scheduled a formal hearing in July to review 7 peptides including BPC 157 and TB 500 for legal compounding. , This isnt approval. But its FDA Compliance for Peptide Therapy and BPC 157 Holt Law AP's BPC 157 peptide warning skips every doctor who disagrees Seattle Red BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest BREAKING: The FDA just made it official. Advisory committee meetings are now scheduled for July 23 24 to review reclassifying peptides back to legal compounding status. Here's what's happening: After the